Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study

By Boellner Samuel W.   Earl Craig Q.   Arora Sanjay  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2457-2465

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of oral tipepidine administration for children with attention deficit/hyperactivity disorder: A 4‐week, open‐label clinical study

By  

PSYCHIATRY AND CLINICAL NEUROSCIENCES, Vol. 69, Iss. 10, 2015-10 ,pp. : 658-659

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

By Prasad Suyash   Harpin Val   Poole Lynne   Zeitlin Harry   Jamdar Saroj   Puvanendran Kanagasabai    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 379-394

Informa Healthcare

Access to resources Recommend Favorite

Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder

By Fallu Angelo   Richard Caroline   Prinzo Rosanna   Binder Carin  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2557-2566

Informa Healthcare

Access to resources Recommend Favorite

Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder

By Turgay Atilla  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 19-38

Future Medicine

Access to resources Recommend Favorite